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Riyadh, Saudi Arabia 
The autologous pulmonary valve was translocated into the 
mitral valve position in a rheumatic and symptomatic 12-year-
old girl with severe mitral valve regurgitation. The top hat 
technique was used. The native mitral valve was totally pre-
served. The patient continues to do well with a normally func-
tioning translocated pulmonary autograft after 6 years of fol-
low-up. We propose to call this procedure the "Ross II 
procedure." 
Clinical summary. A 12-year-old girl weighing 30 kg with 
a body surface area of 1.16 m2 was referred to us with the 
diagnosis of severe rheumatic mitral valve regurgitation. She 
was in New York Heart Association class III-IV despite 
receiving diuretics and angiotensin-converting enzyme 
inhibitors. Both weight and height were below the fifth per-
centile for age. She had signs and symptoms of severe mitral 
valve regurgitation. A 2-dimensional echocardiogram demon-
strated a rheumatic mitral valve with large lack of coaptation 
of valve leaflets, prolapse of the anterior leafiet, and thicken-
ing of the tips of both leaflets. There was severe mitral regur-
gitation with an eccentric jet, which was directed posteriorly 
and filled a massively dilated left atrium. The other valves 
were normal. The left ventricle was dilated but had normal 
systolic function. 
The patient was operated on with the use of routine car-
diopulmonary bypass and retrograde continuous warm blood 
cardioplegia. The mitral valve appearance was consistent with 
healed rheumatic valvulitis with a severely thickened, retract-
ed posterior leaflet. The anterior leaflet was thin and pliable 
with mild prolapse. An attempt at repairing the valve was 
unsuccessful. Because of the patient's age and unsuitability 
for permanent anticoagulation, we decided to use the patient's 
own pulmonary valve. The pulmonary valve was harvested 
and implanted inverted in the mitral position inside a 26-mm 
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Dacron tube, a technique described by Yacoub and Kittle l as 
"the top hat." The native valve was left intact in its position. 
Right ventricular-pulmonary artery continuity was re-estab-
lished with a size 24 cryopreserved pulmonary homograft. 
An intraoperative transesophageal echocardiogram demon-
strated a well-functioning pulmonary autograft in the mitral 
position with only trivial regurgitation and no restriction to 
t10w. The pulmonary homograft in the pulmonary position 
was also functioning well with no pulmonary stenosis or re-
gurgitation. The native mitral valve was seen in the left ven-
tricle with preserved mitral annular contraction. Both ventri-
cles showed normal systolic function. The patient made an 
uneventful recovery. 
The patient has had annual follow-up examinations, includ-
ing complete transthoracic 2-dimensional echocardiographic 
assessment. She is free of symptoms in New York Heart 
A,sociation class I and continues to thrive. Her maintenance 
drug program includes oral penicillin V prophylaxis 250 mg 
twice daily and aspirin 100 mg daily. The latest echocardio-
gram 6 years later showed the pulmonary autograft in the 
mitral position functioning well with mild thickening of the 
cusps (Fig 1). There was mild mitral regurgitation and a mean 
diastolic gradient of 8 mm Hg. The effective orifice area was 
calculated as 1.7 cm2 Left atrial size had decreased signifi-
cantly and both ventricles were normal in size and function 
(Fig 2). The pulmonary homograft in the pulmonary position 
functioned normally. 
Discussion. Valvular repairs are preferable but not feasible 
all the time. Valvular replacement with a mechanical prosthe-
sis or bioprosthesis is not without drawbacks. Homograft 
replacement has inherent limitations of acellularity, degenera-
tive changes, calcification, and limited life span. The search 
for an ideal valvular replacement that would resist degenera-
tion and infection. has a good effective orifice area, low pres-
sure gradients, and freedom from thromboembolic conse-
quences or leak is still far from reach." This would be 
particularly important in young persons to avoid a lifetime of 
anticoagulation or the possibility of increasingly hazardous 
reoperations. 
Aortic valve replacement with the pulmonary autograft (the 
Ross operation) is a good option, and in several cohorts of 
patients impressive results have been demonstrated.2.l 
Although the use of the pulmonary autograft in the mitral 
position was mentioned in Ross's original article,4 only one 
report of implanting the native pulmonary valve in the mitral 
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Fig 1. Apical 4-chamber echocardiographic view of the pulmonary autograft in the mitral position 6 years after 
the operation. A, Systolic frame. B, Diastolic frame. LA, Left atrium; LV, left ventricle; MV, mitral valve; pv, pul-
monary autograft in mitral position; RA, right atrium; RV, right ventricle; HR, heart rate. 
Fig 2. A, Doppler flow imaging showing very mild regurgitation of the autograft and B, continuous wave Doppler, 
Mean diastolic gradient = 8 mm Hg. Vmax, Maximum velocity; Vmean, mean velocity; Pmax, maximum pres-
sure; Pmean, mean pressure; VTI, velocity time interval. For other abbreviations see Fig 1. 
position has appeared in the recent medicalliterature.5 Ross 
had an initial series, but unfortunately the follow-up is frag-
mentary. Nevertheless, he demonstrated that the technique is 
feasible and that the pulmonary valve can function well 
inverted in the mitral position for up to 14 years.5 
The pulmonary autograft proved tolerant to the high sys-
temic pressure. The cusps slowly thickened and adapted to 
the new situation. It has also been reported that explanted 
valves showed normal cusp cellularity with no evidence of 
tissue degeneration.2 The autograft has the advantage of 
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being living autogenous tissue. Hence the potential for 
growth exists when the pulmonary autograft is used in the 
aortic position, and that is the reason the Ross operation is 
considered ideal for aortic valve replacements in infants and 
children. However, the potential for growth is lost when the 
pulmonary autograft is used in the mitral position because it 
has to be housed within the Dacron tube. On the other hand, 
inasmuch as the autograft is lying in the left atrium as a top 
hat, a partial or total preservation of the mitral valve appara-
tus is feasible, as was done in our patient. The autograft is a 
living autogenous tissue, fully flexible, and it cannot obstruct 
the left ventricular outflow tract because of its position inside 
the left atrium (Figs I and 2). 
The improved clinical condition of our patient, freedom 
from anticoagulation, absence of thromboembolism, and the 
maintained excellent performance of the pulmonary autograft 
in the mitral position 6 years later cautiously support this pro-
cedure as a viable alternative in specific clinical situations 
requiring replacement of the mitral valve. However, a larger 
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number of patients is needed with longer follow-up periods 
before one can confidently advocate this procedure. Inas-
much as it is another innovation from a pioneer surgeon, we 
suggest calling this procedure the Ross II procedure. 
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PARTIAL LEFT VENTRICULECTOMY IN AN INFANT WITH DILATED CARDIOMYOPATHY 
Shinpei Yoshii, MD,a Shigeru Hosaka, MD,a Wataru Takahashi, MD,a Hiroshi Amano, MD,a Samuel J. K. Abraham, MD,a 
Shigeaki Kaga, MD,a Yusuke Tada, MD,a Hisashi Sugiyama, MD,b and Jun Yanai, MD,b Yamanashi, Japan 
Partial left ventriculectomy for dilated cardiomyopathy 
(DCM) was first reported by Batista and associates l in 1996. 
Several authors have reported their clinical experience with 
this operation in adults. l ·3 However, its use in infants has· not 
been reported. We have performed partial left ventriculecto-
my in an infant with DCM. 
Clinical summary. A 5-month-old girl was admitted on an 
emergency basis with symptoms of severe congestive heart 
failure. The cardiothoracic ratio (CTR) on chest radiography 
was 67%. Echocardiography revealed left ventricular dilata-
tion and a thin myocardium. At the apex, sponge-like 
myocardium4 was detected. The diastolic dimension was 44.5 
mm, the systolic dimension was 42.4 mm, and the ejection 
fraction was 13.5%. The patient was treated with dopamine, 
arnrinone, and furosemide, and her condition stabilized. The 
CTR was reduced from 67% to 63%. 
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Laboratory investigation revealed no signs of acute 
myocarditis. Cardiac catheterization showed normal coronary 
arterial anatomy. Myocardial biopsy revealed no abnormali-
ties. The diagnosis of DCM was made, and conventional 
treatment was started. 
Echocardiography and chest cardiography 2 months later 
revealed an increase in the diameter of the left ventricle and 
a decrease in the ejection fraction. Her general condition was 
deteriorating. Growth hormone therapy5 was started. Mitral 
regurgitation and left ventricular enlargement (diastolic 
dimension, 51.3 mm; systolic dimension, 49.5 mm; ejection 
fraction, 7.4%) wete detected by echocardiography 2 weeks 
later, at which time she became seriously ill. The CTR 
increased to 67% (Fig 1). Reduced urine volume, elevated 
hepatic transaminase concentrations, and metabolic acidosis 
also were detected. Emergency partial left ventriculectomy 
was carried out. The 8-month-old patient weighed 5.2 kg. 
Using cardiopulmonary bypass and cardioplegic arrest, a 
partial left ventriculectomy and mitral valvuloplasty with 
Alfieri repair3 were performed. Transesophageal echocardio-
graphy and continuous monitoring of mixed venous oxygen 
saturation (Svoz) with a thermodilution cannula were used. 
The inner wall of the apex of the left ventricle contained 
sponge-like coarse trabeculations. The posterior left ventric-
ular muscle between the two papillary muscles was resected 
as much as possible, especially at the apex. Weaning from 
cardiopulmonary bypass was smooth. No mitral regurgita-
